News

Filter

Current filters:

None

76 to 85 of 96555 results

Roche posts solid sales performance for first nine months of 2014

Roche posts solid sales performance for first nine months of 2014

16-10-2014

Swiss pharma major Roche this morning released its financials for the first nine months of 2014, showing…

Economy of SwitzerlandFinancialPharmaceuticalRocheSwitzerlandtrastuzumab

AbbVie board withdraws bid to acquire Shire

AbbVie board withdraws bid to acquire Shire

16-10-2014

Following takeover target Shire’s waiver of the three-day notice period, AbbVie said this morning that…

AbbVieIrelandMergers & AcquisitionsPharmaceuticalShireUSA

Dendreon’s Provenge too expensive to be recommended, says NICE in draft guidance

Dendreon’s Provenge too expensive to be recommended, says NICE in draft guidance

16-10-2014

In preliminary draft guidance issued this morning the UK health costs watchdog the National Institute…

BiotechnologyDendreonOncologyPricingProvengeRegulationUK

Age is a factor when looking at diabetes management, Sanofi survey finds

Age is a factor when looking at diabetes management, Sanofi survey finds

15-10-2014

The US subsidiary of French pharma major Sanofi has announced the findings of a new survey that reveals…

DiabetesPharmaceuticalResearchSanofiUSA

Orexigen earns total $100 million milestone on Contrave

Orexigen earns total $100 million milestone on Contrave

15-10-2014

US biopharma company Orexigen Therapeutics says it has earned a $70 million milestone payment from partner…

ContraveFinancialMarkets & MarketingMetabolicsOrexigen TherapeuticsPharmaceuticalTakeda PharmaceuticalUSA

Japan’s Santen sets up its own subsidiary in Italy

Japan’s Santen sets up its own subsidiary in Italy

15-10-2014

Japanese mid-size ophthalmic drugmaker Santen Pharmaceutical says it has established a wholly-owned subsidiary…

CosoptItalyMarkets & MarketingOphthalmicsPharmaceuticalSaflutanSanten Pharmaceuticals

FDA grants priority reviews for Eisai's for rufinamide and lenvatinib

FDA grants priority reviews for Eisai's for rufinamide and lenvatinib

15-10-2014

There was good news for Japanese drugmaker Eisai yesterday, as the US Food and Drug Administration granted…

BanzelEisailenvatinibNeurologicalOncologyPharmaceuticalRegulationRufinamide TabletsUSA

76 to 85 of 96555 results

Back to top